CD34 and diabetes mellitus: A similar pathophysiological mechanism—oxidative stress and reduced bioavailability of nitric oxide in a hyperglycaemic state—could also be attributed to the depletion of the number and function of CD34+ cells in patients with diabetes mellitus [18,19].